# Baseline Validation Report

## Validation Run 001

- Status: completed
- Run ID: `VALIDATION_RUN_001`
- Start Date: `2026-06-18`
- End Date: `2026-06-18`
- Target RFQs: `10`
- Actual RFQs Processed: `10`

## Executive Summary

Validation Run 001 completed with 10 processed RFQs and no recorded failures.
Every RFQ reached submission-ready status under the supervised path.
A manual approval step was recorded for every RFQ.
Quote pack generation and submission pack generation succeeded for all samples.
No proof submission was performed during the run.

## Final Metrics

| Metric | Result |
| --- | ---: |
| RFQs Processed | 10 |
| PASS | 10 |
| FAIL | 0 |
| Submission Ready | 10 |
| Quote Packs Generated | 10 |
| Submission Packs Generated | 10 |
| Manual Approvals Recorded | 10 |
| Total Manual Interventions | 10 |
| Average Manual Interventions per RFQ | 1.0 |
| Failure Categories Observed | 0 |

## Evidence Summary

- RFQ-001 through RFQ-009 followed the same supervised repeat path and produced the same outcome pattern.
- RFQ-010 also completed successfully and remained submission-ready.
- The recurring manual approval dependency was present in every RFQ in the sample.
- No blocking defect interrupted the run.

## Key Findings

1. Supervised pipeline stability was repeatable across the full 10-RFQ sample.
2. Submission readiness was achieved on every RFQ.
3. No failure categories were observed in the validation window.
4. Manual approval remained a consistent operational dependency.

## Open Questions for Phase 2

1. Can the recurring manual intervention be reduced?
2. Can proof submission be validated safely?
3. Does the same performance hold across broader RFQ categories?
4. What happens when explicit failure scenarios are encountered?

## Go / No-Go Assessment

Assessment: `GO WITH CONDITIONS`

Reason:
- The supervised path demonstrated repeatable success across the sampled RFQs.
- Actual submission validation was not exercised during this run.
- The manual approval dependency should be quantified further before any autonomy expansion.

## Closing Note

This report freezes the baseline evidence captured during Validation Run 001.
Future work should use this report and the tracker as the reference point for Phase 2 testing.
